Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Street Walker who wrote (2052)	1/21/2000 5:03:00 PM
From: Street Walker	Respond to of 5582

ZICAM vs Pleconaril ( VPHM ) Pleconaril: Not available for a few years, so no sales. When its approved, it will take patients two days to get into their primary care doctor and a heavy wallet to pay for the medicine. Pleconaril will reduce a 14 day cold down to 10 days. By the time a Pleconaril wanting cold sufferer reaches the doctor, a Zicam using person will already be over the cold. ZICAM: zicam.com gumminvestors.com Available in over 50,000 stores. Increasing production capacity to start filling orders overseas. Someone with a cold just spends $10 at a local store and reduces a 14 day cold to last only 1-3 days. Second Clinicals will reveal the PREVENTION status. Oh, and that one bottle will last through 2 separate colds. I don't want to demean pleconaril as an anti-viral. As a physician, we really need it for serious infections. But for the simple common cold, it does not hold up against Zicam. Regards, S.W.